Certolizumab pegol Active Not Recruiting Phase 3 Trials for Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01550003Pediatric Arthritis Study of Certolizumab Pegol